High-intensity focused ultrasound-induced mechanochemical transduction in synthetic elastomers
View Patent ↗Provided herein are compositions and methods for remotely and non-invasively subjecting targeted biological structures with light emissions or chromogenic changes.
1. A composition comprising a chromogenic or luminescent mechanophore covalently linked to a gel matrix, wherein the chromogenic or luminescent mechanophore is present in the gel matrix at about 1.0 wt % to about 5 wt %, wherein the chromogenic or luminescent mechanophore is naphthopyran, dioxetane, spiropyran, maleimide, or tetraarylsuccinonitrile tetraol, and wherein one or more types of genetically modified cells that express one or more recombinant light sensitive proteins are present within the gel matrix.
2. A composition comprising a chromogenic or luminescent mechanophore covalently linked to a gel matrix, wherein the chromogenic or luminescent mechanophore is present in the gel matrix at about 1.0 wt % to about 5 wt %, wherein the chromogenic or luminescent mechanophore is naphthopyran, dioxetane, spiropyran, maleimide, or tetraarylsuccinonitrile tetraol, and wherein one or more types of genetically modified cells are present within the gel matrix, wherein the composition further comprises an energy acceptor.
3. The composition of claim 2 wherein the energy acceptor is perylene, anthracene, or psoralen.
4. The composition of claim 2 , wherein the energy acceptor is present in the gel matrix at about 0.1 wt % to about 10 wt %.
5. The composition of claim 1 , wherein the matrix is in contact with cells, cell culture, or tissue.
6. A composition comprising anthracene covalently linked to a gel or elastomer matrix, wherein the anthracene is present in the gel or elastomer matrix at about 1.0 wt % to about 5 wt %, wherein one or more types of genetically modified cells that express one or more recombinant light sensitive proteins are present within the gel or elastomer matrix.
7. The composition of claim 6 , wherein the gel or elastomer matrix comprises polydimethylsiloxane (PDMS) or polyethylene glycol (PEG).
8. The composition of claim 6 , wherein the composition further comprises an energy acceptor.
9. The composition of claim 8 , wherein the energy acceptor is perylene, anthracene, or psoralen.
10. The composition of claim 8 , wherein the energy acceptor is present in the gel or elastomer matrix at about 0.1 wt % to about 10 wt %.
11. The composition of claim 6 , wherein the gel or elastomer matrix is in contact with cells, cell culture, or tissue.
12. A composition comprising a chromogenic or luminescent mechanophore covalently linked to a gel or elastomer matrix, wherein the chromogenic or luminescent mechanophore is present in the gel or elastomer matrix at about 1.0 wt % to about 5 wt %, wherein one or more types of genetically modified cells are present within the gel or elastomer matrix, and wherein the composition further comprises an energy acceptor that is different from the chromogenic or luminescent mechanophore.
13. The composition of claim 12 , wherein the chromogenic or luminescent mechanophore is naphthopyran, dioxetane, spiropyran, maleimide, anthracene, or tetraarylsuccinonitrile tetraol.
14. The composition of claim 12 , wherein the energy acceptor is perylene, anthracene, or psoralen.
15. The composition of claim 12 , wherein the energy acceptor is present in the gel or elastomer matrix at about 0.1 wt % to about 10 wt %.
16. The composition of claim 12 , wherein the one or more types of genetically modified cells express one or more recombinant light sensitive proteins.
17. The composition of claim 12 , wherein the gel or elastomer matrix is in contact with cells, cell culture, or tissue.